: SAGE: Nicholas B. Lydon

... > health and social care > health and society > cancer and society > key people in cancer and society > Nicholas B. Lydon

Nicholas B. Lydon

CANCER SPECIALIST NICHOLAS B. Lydon was the joint winner, with Brian J. Druker, of the Charles F. Kettering Prize of the General Motors Cancer Foundation in 2002 for “contributions to the identification and clinical development of the tyrosine kinase inhibitor STI-571 (Gleevec™), a prototype ‘targeted therapeutic’ with efficacy in the treatment of patients with chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GIST), and possibly other malignancies.” Nicholas Lydon completed his B.S. from the University of Leeds in England and his doctorate in biochemistry from the Medical Sciences Institute of the University of Dundee, Scotland. His doctoral thesis, which was completed in 1982, was titled Studies on the Hormone-Sensitive Adenylate Cyclase from Bovine Corpus Luteum. [Source: Encyclopedia of Cancer and Society; Lydon, Nicholas B.]

http://data.loterre.fr/ark:/67375/N9J-G2V98QHW-T

RDF/XML TURTLE JSON-LD

Loterre